Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/8/2024 | Buy → Hold | The Benchmark Company | |
| 5/3/2024 | $130.00 | Hold → Buy | Craig Hallum |
| 12/15/2023 | Buy → Neutral | BofA Securities | |
| 9/15/2023 | $225.00 | Buy | BofA Securities |
| 8/4/2023 | $140.00 → $175.00 | Buy → Hold | Craig Hallum |
| 6/14/2023 | Buy → Hold | Needham | |
| 6/5/2023 | Outperform | William Blair | |
| 2/28/2023 | $150.00 | Buy | Loop Capital |
The Benchmark Company downgraded Axcelis Tech from Buy to Hold
Craig Hallum upgraded Axcelis Tech from Hold to Buy and set a new price target of $130.00
BofA Securities downgraded Axcelis Tech from Buy to Neutral
10-Q - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
10-Q - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
BEVERLY, Mass., Nov. 19, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that management will participate in the following investor conferences: 2024 Wells Fargo TMT Summit, taking place at the Terranea Resort in Rancho Palos Verdes, CA on December 3 and 4, 2024. Axcelis management will host one-on-one meetings on December 3, 2024, with interested investors. For more information on the conference, or to schedule a one-on-one meeting, please contact a Wells F
Revenue of $256.6 millionOperating margin of 18.3% Diluted earnings per share of $1.49BEVERLY, Mass., Nov. 6, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the third quarter ended September 30, 2024. The Company reported third quarter revenue of $256.6 million, compared to $256.5 million for the second quarter of 2024. Gross margin for the quarter was 42.9%, compared to 43.8% in the second quarter. Operating profit for the quarter was $46.9 million, compared to $52.8 million for the second quarter. Net income for the quarter was $48.6 million, or $1.49 per diluted share, compared to $50.9 million, or $1.55 per diluted share in the second
BEVERLY, Mass., Oct. 16, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the third quarter 2024 on Wednesday, November 6, 2024, at 4:00 p.m. ET. The Company will host a call to discuss the results for the third quarter 2024 on Thursday, November 7, 2024, at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a Participant here: https://register.vevent.com/register/BI64036dd04ee74de4bea3e1ba939fae67
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4/A - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4/A - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
Axcelis Technologies's (NYSE:ACLS) short percent of float has risen 19.37% since its last report. The company recently reported that it has 2.19 million shares sold short, which is 9.92% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.6 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short in
DA Davidson analyst Thomas Diffely maintains Axcelis Technologies (NASDAQ:ACLS) with a Buy and raises the price target from $150 to $175.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler cut the price target for Schlumberger Limited (NYSE:SLB) from $71 to $66. Piper Sandler analyst Luke Lemoine maintained an Overweight rating. SLB shares gained 0.5% to close at $46.42 on Friday. See how other analysts view this stock. Oppenheimer boosted the price target for The Trade Desk, Inc. (NASDAQ:TTD) from $105 to $120. Oppenheimer analyst Jason Helfstein maintained an Outperform rating. Trade Desk shares gained 0.9% to close at $99.44 on Friday. See how other analysts view thi
Revenue of $256.6 millionOperating margin of 18.3% Diluted earnings per share of $1.49BEVERLY, Mass., Nov. 6, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the third quarter ended September 30, 2024. The Company reported third quarter revenue of $256.6 million, compared to $256.5 million for the second quarter of 2024. Gross margin for the quarter was 42.9%, compared to 43.8% in the second quarter. Operating profit for the quarter was $46.9 million, compared to $52.8 million for the second quarter. Net income for the quarter was $48.6 million, or $1.49 per diluted share, compared to $50.9 million, or $1.55 per diluted share in the second
BEVERLY, Mass., Oct. 16, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the third quarter 2024 on Wednesday, November 6, 2024, at 4:00 p.m. ET. The Company will host a call to discuss the results for the third quarter 2024 on Thursday, November 7, 2024, at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a Participant here: https://register.vevent.com/register/BI64036dd04ee74de4bea3e1ba939fae67
Revenue of $256.5 millionOperating margin of 20.6% Diluted earnings per share of $1.55 BEVERLY, Mass., July 31, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the second quarter ended June 30, 2024. The Company reported second quarter revenue of $256.5 million, compared to $252.4 million for the first quarter of 2024. Gross margin for the quarter was 43.8%, compared to 46.0% in the first quarter. Operating profit for the quarter was $52.8 million, compared to $56.5 million for the first quarter. Net income for the quarter was $50.9 million, or $1.55 per diluted share, compared to $51.6 million, or $1.57 per diluted share in the first quart
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
The Company Announces Planned Retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy BEVERLY, Mass., June 27, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today named David Ryzhik as Senior Vice President of Investor Relations and Corporate Strategy, assuming responsibility for the role in July 2024. The Company also announced the retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy. Mr. Lawson plans to retire in July 2024 and will remain as a Senior Advisor through July 2025.
BEVERLY, Mass., April 2, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today a shipment of the Company's Purion EXE™ SiC high energy implanter as well as a successful Purion H200™ SiC medium energy implanter evaluation closure at leading power device chipmakers located in Japan. The systems will be used for 150mm and 200mm production of silicon carbide power devices supporting automotive, industrial, energy, and other power intensive applications. Greg Redinbo,
SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company's Board of Directors effective immediately. Ms. Fallon will also become a member of the Company's Audit Committee. Ms. Fallon is the Executive Vice President, HR/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (NASDAQ:ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position sin